Commentary: Epitranscriptomic regulation by m6A in immunity and autoimmune disorders: emerging mechanisms and clinical perspectives
therefore move beyond merely acknowledging context dependence and instead establish testable, context-resolved frameworks for mechanistic validation and clinical translation.A major risk in current studies of m6A in autoimmune diseases is the overinterpretation of regulator expression. Altered expression of METTL3/METT...